13-45338684-C-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_003295.4(TPT1):c.492G>A(p.Lys164Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00305 in 1,613,412 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0021 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0031 ( 8 hom. )
Consequence
TPT1
NM_003295.4 synonymous
NM_003295.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.53
Genes affected
TPT1 (HGNC:12022): (tumor protein, translationally-controlled 1) This gene encodes a protein that is a regulator of cellular growth and proliferation. Its mRNA is highly structured and contains an oligopyrimidine tract (5'-TOP) in its 5' untranslated region that functions to repress its translation under quiescent conditions. The encoded protein is involved in a variety of cellular pathways, including apoptosis, protein synthesis and cell division. It binds to and stabilizes microtubules, and removal of this protein through phosphorylation is required for progression through mitotic and meiotic cell divisions. This gene is known to play a role in carcinogenesis, and is upregulated in some cancer cells. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant 13-45338684-C-T is Benign according to our data. Variant chr13-45338684-C-T is described in ClinVar as [Benign]. Clinvar id is 734326.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.53 with no splicing effect.
BS2
High AC in GnomAd4 at 321 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPT1 | NM_003295.4 | c.492G>A | p.Lys164Lys | synonymous_variant | Exon 5 of 6 | ENST00000530705.6 | NP_003286.1 | |
TPT1 | NM_001286272.2 | c.492G>A | p.Lys164Lys | synonymous_variant | Exon 5 of 6 | NP_001273201.1 | ||
TPT1 | NM_001286273.2 | c.390G>A | p.Lys130Lys | synonymous_variant | Exon 4 of 5 | NP_001273202.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00211 AC: 321AN: 152116Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
321
AN:
152116
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00206 AC: 515AN: 250508Hom.: 4 AF XY: 0.00208 AC XY: 282AN XY: 135420
GnomAD3 exomes
AF:
AC:
515
AN:
250508
Hom.:
AF XY:
AC XY:
282
AN XY:
135420
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00315 AC: 4599AN: 1461178Hom.: 8 Cov.: 31 AF XY: 0.00312 AC XY: 2268AN XY: 726884
GnomAD4 exome
AF:
AC:
4599
AN:
1461178
Hom.:
Cov.:
31
AF XY:
AC XY:
2268
AN XY:
726884
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00211 AC: 321AN: 152234Hom.: 0 Cov.: 33 AF XY: 0.00199 AC XY: 148AN XY: 74434
GnomAD4 genome
AF:
AC:
321
AN:
152234
Hom.:
Cov.:
33
AF XY:
AC XY:
148
AN XY:
74434
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Jun 08, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at